-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603. Oncogenes and Tumor Suppressors: Poster II

Oncogenes and Tumor Suppressors Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Anna Staffas, PhD1,2*, Yuan Wei, MD, PhD1,3*, Laleh Arabanian1*, Ann Jansson2*, Sara Ståhlman2*, Susanne Li2*, Linda Fogelstrand, MD, PhD2,4, Jörg Cammenga, MD, PhD5, Florian Kuchenbauer, MD, PhD6 and Lars Palmqvist, MD, PhD2,4

1Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
2Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
3Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
4Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
5Molecular Medicine and Gene Therapy, BMC A12, Lund Stem Cell Center, Lund University, Lund, Sweden
6Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

Flávia Adolfo Corrocher, MSc*, Ada Congrains, PhD*, Fernanda Soares Niemann, MSc*, Bruna Palodetto, MSc*, Fernanda Marconi Roversi, PhD*, Mariana Ozello Baratti, PhD*, Paula de Melo Campos, Ph.D.* and Sara Teresinha Olalla Saad, PhD, MD

Hematology and Hemotherapy Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil

Richard L Bennett, Ph.D.1, Michael T. Byrne, DO2, Xiaodong Cheng, MD, PhD1*, Mohini Patel1*, Zeel Patel1*, Amalin Asous1* and W. Stratford May, MD, PhD1

1Department of Medicine, University of Florida, Gainesville, FL
2Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN

Kerstin Wenzl, MSc1*, Katharina Troppan, MD1*, Beata Pursche1*, Marco Bischof2*, Christine Beham-Schmid, MD3*, Hildegard T. Greinix, MD1, Peter Neumeister, MD4* and Alexander JA Deutsch, PhD1*

1Internal Medicine / Hematology, Medical University Graz, Graz, Austria
2Internal Medicine / Hematology, Medical University of Graz, Graz, Austria
3Institute of Pathology / Hematopathology, Medical University Graz, Graz, Austria
4Internal Medicine / Hematology, Medical Universitiy of Graz, Graz, Austria

Marshall S Horwitz, MD, PhD and Matthew R Hart, PhD*

Department of Pathology, University of Washington School of Medicine, Seattle, WA

Anna Staffas, PhD1,2*, Edith Schneider, MSc3*, Linda Fogelstrand, MD, PhD1,4, Linda Röhner3*, Michael Heuser, MD5, Konstanze Döhner, MD3, Hartmut Döhner, MD3*, Arefeh Rouhi, PhD3*, Florian Kuchenbauer, MD, PhD3 and Lars Palmqvist, MD, PhD1,4

1Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
2Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
3Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
4Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
5Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Catherine C. Coombs, MD1, Ahmet Zehir, PhD2*, Sean Devlin, PhD3*, Sumit Middha, PhD2*, Donavan Cheng, PhD2*, Ashwin Kishtagari, MD1*, David M. Hyman4, David Solit, MD5*, Mark Robson, MD6*, Jose Baselga, MD, PhD7*, Maria Arcila, MD8*, Mark Ladanyi, MD2*, Martin S Tallman, MD9*, Ross L. Levine, MD1,4 and Michael Berger, PhD8*

1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Hereditary Cancer & Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
9Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Sha Hao, Ph.D1*, Fang Dong, PhD1*, Wen Zhou, Ph.D2*, Hui Cheng, Ph.D.3*, Shihui Ma, MD1*, Lugui Qiu, MD, PhD1 and Tao Cheng, MD3

1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Tianjin, China
2Cancer Research Institute, Central South University; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education;Key Laboratory of Carcinogenesis, National Health and Family Planning Commission, Changsha, China
3Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Tianjin, China

Paul Sinclair, PhD.1*, Joanna Cheng1*, Prahlad Raninga2*, Rebecca Hanna1*, Shaun Hollern1*, Amir Enshaei, PhD1*, Helen Blair, PhD1*, Sirintra Nakjang1*, Sarra Ryan, PhD1*, Jeyanthy Eswaran, PhD1*, Lars Buechler1*, Olaf Heidenreich, PhD1* and Christine Harrison, PhD FRCPath FMedSci1

1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
2The Eskitis Institute for Drug Discovery, Griffith University, Nathan, Australia

Franz X Schaub1, Weimin Li1*, Mohammad Fallahi2*, Chunying Yang1*, Stephanie K Schaub1*, Soyoung Lee3*, Alexandar Tzankov4*, Clemens Schmitt5, Antonio L Amelio6* and John L. Cleveland1*

1Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL
2Informatics Core, Scripps Florida, The Scripps Research Institute, Jupiter, FL
3Department of Hematology, Oncology and Tumor Immunology, Charité, Universitätsmedizin Berlin, Berlin, Germany
4Department of Pathology, University Hospital of Basel, Basel, Switzerland
5Max-Delbruck Center for Molecular Medicine, Berlin, Germany
6School of Dentistry,Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC

Kevin B Yang1*, Victor Ng, MS2*, Gina Ney, MD, PhD3, Lu Liu, PhD1*, Xi Jin, PhD1* and Qing Li, MD, PhD4

1University of Michigan, Ann Arbor, MI
2New York University School of Medicine, New York City, NY
3Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI
4Hematology/Oncology, University of Michigan, Ann Arbor, MI

Tuoen Liu, MD, PhD1*, Matthew Ndonwi, PhD2* and Matthew J. Walter, MD3

1Department of Medicine, Division of Oncology, Washington University in St Louis, St Louis, MO
2Oncology/Stem Cell Biology, Washington University School of Medicine, St. Louis, MO
3Department of Medicine, Division of Oncology, Washington University in St. Louis, Saint Louis, MO

Carmen Doebele1*, Johannes Kovar1*, Diego Yepes1,2*, Silvia Münch1*, Frank Schnütgen1*, Hanibal Bohnenberger3*, Anne Köhler1*, Henning Urlaub4,5*, Hubert Serve1,2,6 and Thomas Oellerich, MD1,2,7*

1Dept. of Medicine II, Hematology/Oncology, Goethe University Hospital Frankfurt, Frankfurt/Main, Germany
2German Cancer Research Center, Heidelberg, Germany
3Department of Pathology, Georg August University, Goettingen, Germany
4Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
5Bioanalytics, Georg August University, Göttingen, Germany
6German Cancer Consortium, Frankfurt, Germany
7German Cancer Consortium, Heidelberg, Germany

Shan Lin1*, Roger T. Luo, PhD2, Mark Wunderlich, MS1*, Joseph J. Kaberlein2*, Ahmad Rayes, MD, MSc3, John Anastasi, MD2*, Maureen M O'Brien, MD3*, James C. Mulloy, PhD1 and Michael J. Thirman, MD2

1Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2University of Chicago, Chicago, IL
3Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Ewa Jablonska, PhD1*, Patryk Gorniak, PhD1*, Weronika Prusisz, MSc1*, Przemyslaw Kiliszek, MSc1*, Maciej Szydlowski, PhD1*, Tomasz Sewastianik, MSc1*, Emilia Bialopiotrowicz, PhD1*, Anna Polak, MSc1*, Monika Prochorec-Sobieszek, MD, PhD1*, Anna Szumera-Cieckiewicz, MD, PhD1*, Krzysztof Warzocha, MD, PhD2* and Przemyslaw Juszczynski, MD, PhD1*

1Dept. of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
2Dept. of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Bin Lu, Ph.D.1*, Xueqin Sun, Ph.D.1*, John Crispino, PhD2 and Zan Huang1

1College of Life Sciences, Wuhan University, Wuhan, China
2Medicine, Hematology/Oncology, Northwestern University, Chicago, IL

Scott Nadeau, M.S.1*, Wei An, Ph.D.2*, Gulzar Ahmad, Ph.D.3*, Bhopal Mohapatra, Ph.D.3*, Neha Zutshi3*, Matthew Storck, M.S.3*, Seishi Ogawa, MD, PhD4, Vimla Band, Ph.D.3* and Hamid Band, MD, PhD2

1University of Nebraska Medical Center, OMAHA, NE
2Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE
3University of Nebraska Medical Center, Omaha
4Univeristy of Tokyo, Tokyo

Angela Maria Verdoni, PhD1*, Celia Venezia1*, Jeffery Klco, MD PhD2* and Timothy J. Ley, MD3

1Department of Internal Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, St. Louis, MO
2St. Jude Children's Research Hospital, Memphis, TN
3Division of Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO

Elisa Alghisi, PhD1*, Martina Konantz, PhD1*, Marina Mione, MD, PhD2* and Claudia Lengerke, MD1,3

1Department of Biomedicine, University Hospital Basel, Basel, Switzerland
2Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Eggenstein- Leopoldshafen, Germany
3Division of Hematology, University Hospital Basel, Basel, Switzerland

Kerstin Maria Kampa-Schittenhelm, MD1*, Ulrike Mau-Holzmann2*, Lothar Kanz, Prof. Dr. med.3, Charles Lopez, MD, PhD4 and Marcus M Schittenhelm, MD5

1Department of Oncology, Hematology, Rheumatology, Immunology and Pulmology, University of Tuebingen, Tuebingen, Germany
2University of Tuebingen, Tuebingen, Germany
3Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
4Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR
5Dept. of Oncology, Hematology, Rheumatology, Immunology and Pulmology, University of Tuebingen, Tuebingen, Germany

*signifies non-member of ASH